n.a. (TZYM)

0.00
NASDAQ
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange NASDAQ
Div & Yield N.A. (N.A)

Latest News

Tranzyme Pharma Announces Successful Completion Of Drug Discovery Collaboration With Bristol-Myers Squibb

Tranzyme Pharma Announces Successful Completion Of Drug Discovery Collaboration With Bristol-Myers Squibb

Compounds Transferred to Bristol-Myers Squibb for Further Development

Tranzyme Stomach Paralysis Drug Comes Up Short

Tranzyme Stomach Paralysis Drug Comes Up Short

A mid-stage study of Tranzyme's TZP-102 failed to improve stomach mobility in diabetics.

Tranzyme Pharma Announces Second Quarter 2012 Financial Results

Tranzyme Pharma Announces Second Quarter 2012 Financial Results

Company Completes Patient Enrollment in TZP-102 Phase 2b Trial

5 Stocks Under $10 Poised to Move Higher

5 Stocks Under $10 Poised to Move Higher

Traders savvy enough to follow the low-priced names and trade them with discipline and sound risk management are banking ridiculous coin on a regular basis.

Insiders Trading TZYM, ALKS, CAKE

Insiders Trading TZYM, ALKS, CAKE

The top 10 open-market insider purchases and sales filed at the SEC Wednesday.

For Biotech, 'Fail' is Making a Big Comeback

For Biotech, 'Fail' is Making a Big Comeback

A series of disappointments and setbacks is cooling off the once red-hot biotech sector.

Gentris Corporation Announces Changes To Board Of Directors

Dr. David Drutz Becomes Chair; Tim Gupton Joins Board